{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:21:03Z","timestamp":1778775663936,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC 31570163"],"award-info":[{"award-number":["NSFC 31570163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Major Project for Innovative Pharmaceuticals","award":["2015ZX09J15105-002"],"award-info":[{"award-number":["2015ZX09J15105-002"]}]},{"name":"Science and Technology Projects of Guangzhou","award":["201504010032"],"award-info":[{"award-number":["201504010032"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2016A030313572"],"award-info":[{"award-number":["2016A030313572"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.virusres.2018.08.007","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T13:32:11Z","timestamp":1533648731000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Identification of adenovirus neutralizing antigens using capsid chimeric viruses"],"prefix":"10.1016","volume":"256","author":[{"given":"Tiantian","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virusres.2018.08.007_bib0005","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/JVI.06254-11","article-title":"Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection","volume":"86","author":"Bradley","year":"2012","journal-title":"J. Virol."},{"issue":"9653","key":"10.1016\/j.virusres.2018.08.007_bib0010","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.virusres.2018.08.007_bib0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3201\/eid1105.041211","article-title":"Adenovirus type 7 peptide diversity during outbreak, Korea, 1995-2000","volume":"11","author":"Choi","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.virusres.2018.08.007_bib0020","first-page":"37","article-title":"Severe adenovirus infection in children","volume":"36","author":"Chuang","year":"2003","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"11","key":"10.1016\/j.virusres.2018.08.007_bib0025","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1099\/jgv.0.000947","article-title":"Computational analysis of a species D human adenovirus provides evidence of a novel virus","volume":"98","author":"Espinola","year":"2017","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2018.08.007_bib0030","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.72.3.2388-2397.1998","article-title":"Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity","volume":"72","author":"Gahery-Segard","year":"1998","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2018.08.007_bib0035","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/jvi.70.4.2116-2123.1996","article-title":"Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes","volume":"70","author":"Gall","year":"1996","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2018.08.007_bib0040","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s10096-011-1406-8","article-title":"Detection of three human adenovirus species in adults with acute respiratory infection in China","volume":"31","author":"Guo","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"19","key":"10.1016\/j.virusres.2018.08.007_bib0045","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.77.19.10366-10375.2003","article-title":"Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors","volume":"77","author":"Hong","year":"2003","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2018.08.007_bib0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1086\/519938","article-title":"Outbreak of human adenovirus type 3 infection in a pediatric long-term care facility--Illinois, 2005","volume":"45","author":"James","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.virusres.2018.08.007_bib0055","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1128\/JVI.02650-06","article-title":"New adenovirus species found in a patient presenting with gastroenteritis","volume":"81","author":"Jones","year":"2007","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2018.08.007_bib0060","doi-asserted-by":"crossref","first-page":"e53614","DOI":"10.1371\/journal.pone.0053614","article-title":"Adenovirus serotype 3 and 7 infection with acute respiratory failure in children in Taiwan, 2010\u20132011","volume":"8","author":"Lai","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.virusres.2018.08.007_bib0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/rmv.589","article-title":"Clinical features and treatment of adenovirus infections","volume":"18","author":"Lenaerts","year":"2008","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2018.08.007_bib0070","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vaccine.2008.10.032","article-title":"A recombinant replication-defective human adenovirus type 3: a vaccine candidate","volume":"27","author":"Li","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.virusres.2018.08.007_bib0075","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0036-1584923","article-title":"Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention","volume":"37","author":"Lynch","year":"2016","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.virusres.2018.08.007_bib0080","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/00006454-200010000-00011","article-title":"Adenovirus 7a: a community-acquired outbreak in a children\u2019s hospital","volume":"19","author":"Mitchell","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"4","key":"10.1016\/j.virusres.2018.08.007_bib0085","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/JVI.02023-06","article-title":"Structure-based identification of a major neutralizing site in an adenovirus hexon","volume":"81","author":"Pichla-Gollon","year":"2007","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.virusres.2018.08.007_bib0090","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1128\/JVI.07076-11","article-title":"Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions","volume":"86","author":"Qiu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.007_bib0095","article-title":"A simple method for estimating fifty percent end points","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"issue":"2","key":"10.1016\/j.virusres.2018.08.007_bib0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcv.2011.02.014","article-title":"Molecular epidemiology and clinical presentation of human adenovirus infections in Kansas City children","volume":"51","author":"Selvaraju","year":"2011","journal-title":"J. Clin. Virol."},{"issue":"11","key":"10.1016\/j.virusres.2018.08.007_bib0105","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1128\/JVI.00354-11","article-title":"Using the whole-genome sequence to characterize and name human adenoviruses","volume":"85","author":"Seto","year":"2011","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2018.08.007_bib0110","doi-asserted-by":"crossref","first-page":"e0156984","DOI":"10.1371\/journal.pone.0156984","article-title":"Human adenovirus serotype 3 vector packaged by a rare serotype 14 hexon","volume":"11","author":"Su","year":"2016","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.virusres.2018.08.007_bib0115","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"Sumida","year":"2005","journal-title":"J. Immunol."},{"issue":"1-2","key":"10.1016\/j.virusres.2018.08.007_bib0120","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.virusres.2011.06.017","article-title":"Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon","volume":"160","author":"Tian","year":"2011","journal-title":"Virus Res."},{"issue":"10","key":"10.1016\/j.virusres.2018.08.007_bib0125","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.3390\/v7102896","article-title":"Identification and application of neutralizing epitopes of human adenovirus type 55 hexon protein","volume":"7","author":"Tian","year":"2015","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.virusres.2018.08.007_bib0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/10430340252769824","article-title":"Hexon gene switch strategy for the generation of chimeric recombinant adenovirus","volume":"13","author":"Youil","year":"2002","journal-title":"Hum. Gene Ther."},{"issue":"2","key":"10.1016\/j.virusres.2018.08.007_bib0135","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.virol.2012.12.014","article-title":"Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera","volume":"437","author":"Yu","year":"2013","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.virusres.2018.08.007_bib0140","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/1348-0421.12074","article-title":"Outbreak of acute respiratory disease caused by human adenovirus type 7 in a military training camp in Shaanxi, China","volume":"57","author":"Yu","year":"2013","journal-title":"Microbiol. Immunol."},{"issue":"Pt 6","key":"10.1016\/j.virusres.2018.08.007_bib0145","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1099\/vir.0.81515-0","article-title":"Comparative genomic analysis of two strains of human adenovirus type 3 isolated from children with acute respiratory infection in southern China","volume":"87","author":"Zhang","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.virusres.2018.08.007_bib0150","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.vaccine.2008.12.039","article-title":"Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.virusres.2018.08.007_bib0155","doi-asserted-by":"crossref","first-page":"9949","DOI":"10.1364\/AO.54.009949","article-title":"Characterization of polarizer made of the deep-UV birefringent crystal Ba2Mg(B3O6)2","volume":"54","author":"Zhao","year":"2015","journal-title":"Appl. Opt."},{"issue":"8","key":"10.1016\/j.virusres.2018.08.007_bib0160","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1600-0463.2012.02890.x","article-title":"Human adenovirus infection in children with acute respiratory tract disease in Guangzhou, China","volume":"120","author":"Zou","year":"2012","journal-title":"APMIS"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218300881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218300881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:05:53Z","timestamp":1759154753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170218300881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":32,"alternative-id":["S0168170218300881"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2018.08.007","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of adenovirus neutralizing antigens using capsid chimeric viruses","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2018.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}